246 related articles for article (PubMed ID: 7830109)
1. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
2. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
3. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
4. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
[TBL] [Abstract][Full Text] [Related]
5. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
[TBL] [Abstract][Full Text] [Related]
6. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
[TBL] [Abstract][Full Text] [Related]
7. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.
Tamaki N; Ohtani H; Yamashita K; Magata Y; Yonekura Y; Nohara R; Kambara H; Kawai C; Hirata K; Ban T
J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806
[TBL] [Abstract][Full Text] [Related]
9. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
[TBL] [Abstract][Full Text] [Related]
10. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
11. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
[TBL] [Abstract][Full Text] [Related]
12. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
[TBL] [Abstract][Full Text] [Related]
14. Metabolic myocardial viability assessment with iodine 123-16-iodo-3-methylhexadecanoic acid in recent myocardial infarction: comparison with thallium-201 and fluorine-18 fluorodeoxyglucose.
Vanzetto G; Janier M; Fagret D; Cinotti L; André-Fouet X; Comet M; Machecourt J
Eur J Nucl Med; 1997 Feb; 24(2):170-8. PubMed ID: 9021114
[TBL] [Abstract][Full Text] [Related]
15. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution.
Marin-Neto JA; Dilsizian V; Arrighi JA; Freedman NM; Perrone-Filardi P; Bacharach SL; Bonow RO
Circulation; 1993 Oct; 88(4 Pt 1):1736-45. PubMed ID: 8403320
[TBL] [Abstract][Full Text] [Related]
16. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
[TBL] [Abstract][Full Text] [Related]
17. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
[TBL] [Abstract][Full Text] [Related]
18. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
[TBL] [Abstract][Full Text] [Related]
19. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
